Dr. Adam Goldman is an academic researcher affiliated with Tel Aviv University, Tel Aviv-Yafo, Israel, with expertise spanning clinical medicine, gastroenterology, pulmonology, and pharmacovigilance. He has authored 31 peer-reviewed publications, which together have received over 757 citations, reflecting the steady scholarly impact of his work, and he holds an h-index of 12. Dr. Goldman’s research focuses on evidence-based clinical outcomes, safety evaluation of therapeutic interventions, and the application of data-driven approaches in patient care, including studies on pneumonia management, inflammatory bowel disease surveillance, and drug safety in older adults. His work is published in reputable international journals and involves collaboration with a broad global network of researchers, as reflected by extensive co-authorships. Collectively, his contributions support improved clinical decision-making, patient safety, and healthcare quality, offering meaningful societal impact through translational and outcomes-oriented medical research.